Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 9:02 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 865–888 of 33,144 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Placebo Clear all

Conditions: Methamphetamine Dependence
Interventions: Lobeline; Drug
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Nosocomial Infections
Interventions: Talactoferrin, Placebo; Drug
Lead sponsor: Agennix; Industry
Eligibility: 1 Minute to 24 Hours
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 4
States / cities: Los Angeles, California • Louisville, Kentucky • Columbia, Missouri

Conditions: Alzheimer Disease
Interventions: MAR; Drug
Lead sponsor: Noah Pharmaceuticals, Inc.; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 16
States / cities: Scottsdale, Arizona • Huntington Beach, California • DeLand, Florida + 11 more

Conditions: Type II Diabetes
Interventions: Farxiga, Placebo, Metformin, Insulin; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 26
States / cities: Birmingham, Alabama • Phoenix, Arizona • Huntington Park, California + 23 more

Conditions: Cognition Disorders
Interventions: Cognitive Strategy Training, Placebo comparison group; Behavioral · Other
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 4
States / cities: San Diego, California • Boise, Idaho • Portland, Oregon + 1 more

Conditions: Pain
Interventions: bupivacaine liposome injectable suspension, Placebo; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 14
States / cities: Mobile, Alabama • Englewood, Colorado • Miami, Florida + 9 more

Conditions: Post-Traumatic Headache
Interventions: Placebo oral capsule, Low Dose Psilocybin, High Dose Psilocybin; Drug
Lead sponsor: Yale University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Healthy
Interventions: G03-52-01, Placebo; Drug
Lead sponsor: Alachua Government Services, Inc.; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Memory Impairment
Interventions: Vilazodone, Placebo, Hydrocortisone; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 50 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency, Carnitine Palmitoyltransferase Deficiency 2, Very Long Chain Acyl Coa Dehydrogenase Deficiency, Trifunctional Protein Deficiency
Interventions: Nutritional Ketone Supplement, Isocaloric Placebo Supplement; Dietary Supplement
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: The Frailty Syndrome
Interventions: Ghrelin Group 1, Ghrelin Group 2; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 70 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diarrhea, HIV Infections
Interventions: Crofelemer; Drug
Lead sponsor: Shaman Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 34
States / cities: Scottsdale, Arizona • Los Angeles, California • Palo Alto, California + 25 more

Conditions: Metabolic Syndrome
Interventions: Rimonabant, Placebo (for Rimonabant), Mild hypocaloric diet; Drug · Other
Lead sponsor: Sanofi; Industry
Eligibility: 35 Years to 70 Years
Enrollment: 254 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Fatigue, Hypothyroidism
Interventions: Aromatherapy Blend, Placebo; Other
Lead sponsor: Nutraceuticals Research Institute; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Franklin, Tennessee

Conditions: Major Depressive Disorder
Interventions: LY2216684, Placebo, SSRI; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 1,056 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 20
States / cities: Garden Grove, California • Oakland, California • Temecula, California + 17 more

Conditions: Rheumatoid Arthritis
Interventions: Abatacept, Methotrexate, Abatacept Placebo, Methotrexate Placebo; Drug · Other
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 994 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 42
States / cities: Huntsville, Alabama • Glendale, Arizona • Mesa, Arizona + 36 more

Conditions: Congestive Heart Failure, Cardiomyopathy
Interventions: B-type Natriuretic Peptide (BNP), Placebo; Drug · Other
Lead sponsor: Horng Chen; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2010
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Femoral Neck Fractures, Hip Fractures
Interventions: Femoral nerve block: 25 mL of 0.5% bupivacaine, Placebo: 3cc of 0.9% Normal Saline; Drug
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 55 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: COVID 19, SARS-CoV 2, Pneumonia
Interventions: Mavrilimumab, Placebo; Drug
Lead sponsor: Kristin Hudock; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Postoperative Nausea and Vomiting
Interventions: Olanzapine, Placebo; Drug
Lead sponsor: Jaime B Hyman; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: COVID 19 Disease
Interventions: Tafenoquine Oral Tablet, Placebo; Drug
Lead sponsor: 60 Degrees Pharmaceuticals LLC; Industry
Eligibility: 18 Years and older
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 10
States / cities: Miami, Florida • Elkhorn, Nebraska • Morgantown, North Carolina + 4 more

Conditions: HIV Associate Weight Loss
Interventions: Testosterone enanthate, Placebo; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Obsessive Compulsive Disorder
Interventions: glycine, placebo; Drug · Other
Lead sponsor: Nathan Kline Institute for Psychiatric Research; Other
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Orangeburg, New York

Conditions: Mood
Interventions: Botulinum Neurotoxin, Placebo; Drug
Lead sponsor: DeNova Research; Other
Eligibility: 10 Years to 75 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

Ph1 Lobeline Interaction Study - 1

Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants

Phase 2 Estimation Study of Fixed Dose Drugs Combination Type of Polypill

Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin

Cognitive Rehabilitation of Operations Iraqi Freedom and Enduring Freedom (OIF/OEF) Veterans With Cognitive Disorder

Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in Total Knee Arthroplasty

Effects of Psilocybin in Concussion Headache

Study to Evaluate Safety and PK of a Single IM Dose of G03-52-01 vs Placebo in Adult Subjects

Vilazodone for Corticosteroid-Induced Memory Impairment

Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation Disorders

Ghrelin Dose Finding In Frail Elderly

A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients

VIsceral Fat Reduction Assessed by CT-scan On RImonabAnt

The Effect of Aroma on Fatigue Scores Among Women With Hypothyroidism

A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Effects of Abatacept in Patients With Early Rheumatoid Arthritis

Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure

Ultrasound-guided Femoral Nerve Blocks in Elderly Patients With Hip Fractures

Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation

Olanzapine for Nausea After Surgery

Tafenoquine in Patients With Mild to Moderate COVID-19

Testosterone and Physical Function in HIV+ Men

Adjunctive Glycine for Obsessive Compulsive Disorder

Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction